Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
29 participants
INTERVENTIONAL
2024-11-07
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, this study aims to investigate the effect of eyelid closure on the quality index of keratometric measurements in patients with a warning for the quality of keratometric measurements. For this purpose, a single study day including 4 repeated measurements (2 without and 2 with lid closure for 3 minutes) using an ocular biometer (IOLMaster700) will be performed.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SEQUENTIAL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with a keratometrical warning index
The following measurements will be performed in the mentioned order during the visit 1 only in the randomized study eye:
1. First and second biometry using IOLMasterĀ® 700 (2x, 3 minutes pause between the measurements, eyes open, normal blinking)
2. Eyelid closure for 3 minutes
3. Third biometry using IOLMasterĀ® 700 (1x) right after opening of the eyelid
4. Eyelid closure for 3 minutes
5. Fourth biometry using IOLMasterĀ® 700 (1x) right after opening of the eyelid
Eyelid closure for 3 minutes
Patients will be advised to close their eyes for 3 minutes before the third and before the fourth study measurement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eyelid closure for 3 minutes
Patients will be advised to close their eyes for 3 minutes before the third and before the fourth study measurement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent
* Keratometry quality index "warning"
Exclusion Criteria
* Pregnancy (pregnancy test will be taken in women of reproductive age), nursing women
* Ocular surgery in the study eye in the three months preceding the study
* Inability of visual fixation (e.g. in patients with nystagmus)
* Inability of eyelid closure (e.g. in patients with facial nerve paralysis)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vienna Institute for Research in Ocular Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prim. Prof. Dr. Oliver Findl, MBA
Head of Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vienna Institute for Research in Ocular Surgery (VIROS), Department of Ophthalmology
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Manuel Ruiss, MSc
Role: primary
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK 24-111-0824
Identifier Type: -
Identifier Source: org_study_id